Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial

Optimized regimens of combined medications for the treatment of major depressive disorder: a double-blind, randomized-controlled trial

Zoë Zuilhof, Sandhaya Norris, Claude Blondeau, Pierre Tessier, Pierre Blier Department of Psychiatry, University of Ottawa, The Royal Ottawa Institute of Mental Health Research, Ottawa, ON, Canada Introduction: This study investigated if optimized dose regimens of escitalopram and bupropi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zuilhof Z, Norris S, Blondeau C, Tessier P, Blier P
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
antidepressant
escitalopram
bupropion
action onset
augmentation
prolongation
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Acceso en línea:https://doaj.org/article/9d33968dcc3f457d80e20b1b7ceec6e4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/9d33968dcc3f457d80e20b1b7ceec6e4

Ejemplares similares